Concourse Financial Group Securities, Inc. Tenaya Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$0.39 - $0.69 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	BUY	$0.44 - $1.52 $0 - $0	0 New	0 $0
Q4 2024 Feb 13, 2025	BUY	$1.23 - $3.78 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$1.93 - $3.99 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$2.72 - $4.99 $0 - $0	0 New	0 $0

Q1 2024 Apr 30, 2024	BUY	$2.88 - $6.8 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$1.73 - $3.39 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$2.55 - $5.65 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$2.55 - $5.65 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$2.64 - $7.64 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$1.92 - $3.59 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$1.68 - $3.19 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$2.9 - $5.88 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$5.01 - $14.12 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$9.41 - $19.3 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$18.41 - $29.58 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$15.35 - $26.66 $0 - $0	0 New	0 $0

Others Institutions Holding TNYA

# of Institutions

Shares Held

38.7M

Call Options Held

313K

Put Options Held

61.1K

Column Group LLC San Francisco, CA

9.4M
Shares

$12.8 Million
18.17% of portfolio
Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$6.89 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.5M
Shares

$6.13 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.07M
Shares

$5.54 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.68M
Shares

$2.28 Million
0.0% of portfolio

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $56.3M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account